drugset / Trial / NCT00803868
Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
Phase 2/3
Terminated
28 enrolled
University of South Florida
Friedreich's Ataxia Research Alliance · collabPfizer · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if varenicline is effective in treating symptoms of Friedreich's ataxia.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-05
- Completion
- 2010-05
Outcome
Outcome not reported
Stopped: “The DSMB recommended that the study be stopped as a result of concerns regarding safety and intolerability and insufficient evidence of efficacy.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varenicline | Small molecule | 1 mg | Oral |